The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.3 Market by Application
1.3.1 Global Cell Therapy and Tissue Engineering Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cell Defects
1.3.3 Genetic Diseases
1.3.4 Neurodegenerative Diseases
1.3.5 Tissue Malignancies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy and Tissue Engineering Market Perspective (2019-2030)
2.2 Cell Therapy and Tissue Engineering Growth Trends by Region
2.2.1 Global Cell Therapy and Tissue Engineering Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell Therapy and Tissue Engineering Historic Market Size by Region (2019-2024)
2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Region (2025-2030)
2.3 Cell Therapy and Tissue Engineering Market Dynamics
2.3.1 Cell Therapy and Tissue Engineering Industry Trends
2.3.2 Cell Therapy and Tissue Engineering Market Drivers
2.3.3 Cell Therapy and Tissue Engineering Market Challenges
2.3.4 Cell Therapy and Tissue Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue
3.1.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue (2019-2024)
3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2019-2024)
3.2 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue
3.4 Global Cell Therapy and Tissue Engineering Market Concentration Ratio
3.4.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2023
3.5 Cell Therapy and Tissue Engineering Key Players Head office and Area Served
3.6 Key Players Cell Therapy and Tissue Engineering Product Solution and Service
3.7 Date of Enter into Cell Therapy and Tissue Engineering Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy and Tissue Engineering Breakdown Data by Type
4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2019-2024)
4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2025-2030)
5 Cell Therapy and Tissue Engineering Breakdown Data by Application
5.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Application (2019-2024)
5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell Therapy and Tissue Engineering Market Size (2019-2030)
6.2 North America Cell Therapy and Tissue Engineering Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
6.4 North America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Therapy and Tissue Engineering Market Size (2019-2030)
7.2 Europe Cell Therapy and Tissue Engineering Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
7.4 Europe Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy and Tissue Engineering Market Size (2019-2030)
8.2 Asia-Pacific Cell Therapy and Tissue Engineering Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Therapy and Tissue Engineering Market Size (2019-2030)
9.2 Latin America Cell Therapy and Tissue Engineering Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
9.4 Latin America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy and Tissue Engineering Market Size (2019-2030)
10.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Betalin Therapeutics
11.1.1 Betalin Therapeutics Company Detail
11.1.2 Betalin Therapeutics Business Overview
11.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction
11.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.1.5 Betalin Therapeutics Recent Development
11.2 BioCardia, Inc
11.2.1 BioCardia, Inc Company Detail
11.2.2 BioCardia, Inc Business Overview
11.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction
11.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.2.5 BioCardia, Inc Recent Development
11.3 BioReliance Corporation
11.3.1 BioReliance Corporation Company Detail
11.3.2 BioReliance Corporation Business Overview
11.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction
11.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.3.5 BioReliance Corporation Recent Development
11.4 Biosolution Co.
11.4.1 Biosolution Co. Company Detail
11.4.2 Biosolution Co. Business Overview
11.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction
11.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.4.5 Biosolution Co. Recent Development
11.5 Brainstorm Cell Therapeutics, Inc
11.5.1 Brainstorm Cell Therapeutics, Inc Company Detail
11.5.2 Brainstorm Cell Therapeutics, Inc Business Overview
11.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.5.5 Brainstorm Cell Therapeutics, Inc Recent Development
11.6 MaxCyte, Inc
11.6.1 MaxCyte, Inc Company Detail
11.6.2 MaxCyte, Inc Business Overview
11.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction
11.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.6.5 MaxCyte, Inc Recent Development
11.7 Medigene AG
11.7.1 Medigene AG Company Detail
11.7.2 Medigene AG Business Overview
11.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction
11.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.7.5 Medigene AG Recent Development
11.8 MEDIPOST CO.
11.8.1 MEDIPOST CO. Company Detail
11.8.2 MEDIPOST CO. Business Overview
11.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction
11.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.8.5 MEDIPOST CO. Recent Development
11.9 Mesoblast Limited
11.9.1 Mesoblast Limited Company Detail
11.9.2 Mesoblast Limited Business Overview
11.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction
11.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.9.5 Mesoblast Limited Recent Development
11.10 Miromatrix Medical, Inc.
11.10.1 Miromatrix Medical, Inc. Company Detail
11.10.2 Miromatrix Medical, Inc. Business Overview
11.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction
11.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.10.5 Miromatrix Medical, Inc. Recent Development
11.11 MolMed S.p.A
11.11.1 MolMed S.p.A Company Detail
11.11.2 MolMed S.p.A Business Overview
11.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction
11.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.11.5 MolMed S.p.A Recent Development
11.12 Mustang Bio, Inc
11.12.1 Mustang Bio, Inc Company Detail
11.12.2 Mustang Bio, Inc Business Overview
11.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction
11.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.12.5 Mustang Bio, Inc Recent Development
11.13 NantKwest, Inc.
11.13.1 NantKwest, Inc. Company Detail
11.13.2 NantKwest, Inc. Business Overview
11.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction
11.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.13.5 NantKwest, Inc. Recent Development
11.14 Neuralstem, Inc
11.14.1 Neuralstem, Inc Company Detail
11.14.2 Neuralstem, Inc Business Overview
11.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction
11.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.14.5 Neuralstem, Inc Recent Development
11.15 NexImmune, Inc.
11.15.1 NexImmune, Inc. Company Detail
11.15.2 NexImmune, Inc. Business Overview
11.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction
11.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.15.5 NexImmune, Inc. Recent Development
11.16 Nohla Therapeutics, Inc
11.16.1 Nohla Therapeutics, Inc Company Detail
11.16.2 Nohla Therapeutics, Inc Business Overview
11.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.16.5 Nohla Therapeutics, Inc Recent Development
11.17 ReNeuron Group plc
11.17.1 ReNeuron Group plc Company Detail
11.17.2 ReNeuron Group plc Business Overview
11.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
11.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.17.5 ReNeuron Group plc Recent Development
11.18 Richter-Helm BioLogics GmbH & Co. KG
11.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Detail
11.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
11.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
11.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
11.19 RoosterBio, Inc
11.19.1 RoosterBio, Inc Company Detail
11.19.2 RoosterBio, Inc Business Overview
11.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
11.19.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.19.5 RoosterBio, Inc Recent Development
11.20 RoslinCT
11.20.1 RoslinCT Company Detail
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
11.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.20.5 RoslinCT Recent Development
11.21 Rubius Therapeutics, Inc.
11.21.1 Rubius Therapeutics, Inc. Company Detail
11.21.2 Rubius Therapeutics, Inc. Business Overview
11.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
11.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.21.5 Rubius Therapeutics, Inc. Recent Development
11.22 Sangamo Therapeutics, Inc
11.22.1 Sangamo Therapeutics, Inc Company Detail
11.22.2 Sangamo Therapeutics, Inc Business Overview
11.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.22.5 Sangamo Therapeutics, Inc Recent Development
11.23 Voyager Therapeutics, Inc
11.23.1 Voyager Therapeutics, Inc Company Detail
11.23.2 Voyager Therapeutics, Inc Business Overview
11.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.23.5 Voyager Therapeutics, Inc Recent Development
11.24 Waisman Biomanufacturing
11.24.1 Waisman Biomanufacturing Company Detail
11.24.2 Waisman Biomanufacturing Business Overview
11.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction
11.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.24.5 Waisman Biomanufacturing Recent Development
11.25 WindMIL Therapeutics, Inc.
11.25.1 WindMIL Therapeutics, Inc. Company Detail
11.25.2 WindMIL Therapeutics, Inc. Business Overview
11.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
11.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.25.5 WindMIL Therapeutics, Inc. Recent Development
11.26 Wuxi App Tec, Inc.
11.26.1 Wuxi App Tec, Inc. Company Detail
11.26.2 Wuxi App Tec, Inc. Business Overview
11.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction
11.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.26.5 Wuxi App Tec, Inc. Recent Development
11.27 ReNeuron Group plc
11.27.1 ReNeuron Group plc Company Detail
11.27.2 ReNeuron Group plc Business Overview
11.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
11.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.27.5 ReNeuron Group plc Recent Development
11.28 Richter-Helm BioLogics GmbH & Co. KG
11.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Detail
11.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
11.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
11.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
11.29 RoosterBio, Inc
11.29.1 RoosterBio, Inc Company Detail
11.29.2 RoosterBio, Inc Business Overview
11.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
11.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.29.5 RoosterBio, Inc Recent Development
11.30 RoslinCT
11.30.1 RoslinCT Company Detail
11.30.2 RoslinCT Business Overview
11.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
11.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.30.5 RoslinCT Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details